Trials / Conditions / Ann Arbor Stage I Grade 2 Follicular Lymphoma
Ann Arbor Stage I Grade 2 Follicular Lymphoma
3 registered clinical trials studyying Ann Arbor Stage I Grade 2 Follicular Lymphoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Ultra Low Dose Orbital Radiation Therapy in Treating Patients With Stage I-IV Indolent B-cell Lymphoma or Mant NCT02494700 | M.D. Anderson Cancer Center | Phase 2 |
| Terminated | Rituximab With or Without Yttrium Y-90 Ibritumomab Tiuxetan in Treating Patients With Untreated Follicular Lym NCT02320292 | Mayo Clinic | Phase 3 |
| Active Not Recruiting | Radiation Therapy and Rituximab in Treating Patients With Stage I-II Grade 1 or Grade 2 Follicular Lymphoma NCT01473628 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |